Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Wednesday, June 17th will be paid a dividend of 0.31 per share by the medical instruments supplier on Friday, July 3rd. This represents a c) dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Wednesday, June 17th.
Utah Medical Products has increased its dividend by an average of 0.0%per year over the last three years and has increased its dividend every year for the last 3 years.
Utah Medical Products Stock Down 1.9%
UTMD opened at $63.62 on Wednesday. The firm has a 50-day moving average price of $65.50 and a 200-day moving average price of $61.19. Utah Medical Products has a twelve month low of $52.00 and a twelve month high of $71.81. The company has a market capitalization of $202.30 million, a price-to-earnings ratio of 19.24 and a beta of 0.37.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Thursday, April 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a net margin of 28.90% and a return on equity of 9.17%. The company had revenue of $8.72 million during the quarter.
About Utah Medical Products
(
Get Free Report)
Utah Medical Products, Inc NASDAQ: UTMD, headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.
The company's core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.